Second Sight Medical Products (Second Sight Medical Products) Days Sales Outstanding : 0.00 (As of Jun. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Second Sight Medical Products Days Sales Outstanding?

Second Sight Medical Products's average Accounts Receivable for the three months ended in Jun. 2022 was $0.00 Mil. Second Sight Medical Products's Revenue for the three months ended in Jun. 2022 was $0.00 Mil.

The historical rank and industry rank for Second Sight Medical Products's Days Sales Outstanding or its related term are showing as below:

EYES's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 64.21
* Ranked among companies with meaningful Days Sales Outstanding only.

Second Sight Medical Products's Days Sales Outstanding stayed the same from Jun. 2021 (0.00) to Jun. 2022 (0.00).

Second Sight Medical Products Days Sales Outstanding Historical Data

The historical data trend for Second Sight Medical Products's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Days Sales Outstanding Chart

Second Sight Medical Products Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Sales Outstanding

Get a 7-Day Free Trial

48.24

61.79

51.80

Second Sight Medical Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Second Sight Medical Products's Days Sales Outstanding

For the Medical Devices subindustry, Second Sight Medical Products's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Second Sight Medical Products's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's Days Sales Outstanding falls into.

Second Sight Medical Products Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Second Sight Medical Products's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

	Days Sales Outstanding (A: Dec. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )	/	Revenue (A: Dec. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Second Sight Medical Products's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding (Q: Jun. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Jun. 2022 ))	/	count )	/	Revenue (A: Jun. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Second Sight Medical Products (NAS:EYES) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Second Sight Medical Products Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Second Sight Medical Products (Second Sight Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYES) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

13170 Telfair Avenue, Sylmar, CA, USA, 91342

Website

https://www.secondsight.com

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Executives

Lisa Ellen Porter	officer: Chief Medical Officer	778 CORDILLERAS AVE, SAN CARLOS CA 94070
Donald Dwyer	officer: Chief Business Officer	54 CHERRY FARM LANE, WEST CHESTER PA 19382
Truc Le	officer: COO	1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn	director, officer: CEO	C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Brigid Makes	officer: CFO	20245 SW 95TH AVENUE, TUALATIN OR 97062
Gregg Williams	director, 10 percent owner	PO BOX 200, WALLED LAKE MI 48390-0200
Wilford Dean Baker	director	200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p.	director	3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar	officer: Acting CEO	13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo	officer: Controller	4485 FORESTGLEN CT, MOORPARK CA 93021
Jonathan Will Mcguire	director, officer: Chief Executive Officer	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Jessy Dana Dorn	officer: VP-Clin & Scientific Affairs	12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Edward David Randolph	officer: Vice President Manufacturing	12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR CA 91342
Matthew J Pfeffer	director
Aaron Mendelsohn	director	224 15TH STREET, SANTA MONICA CA 90402